Varian, a Siemens Healthineers company, has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services. This acquisition enhances Varian’s Advanced Oncology Solutions (AOS) offerings, enabling them to address the growing demand for customized services and standardized care in cancer treatment. Varian’s AOS combines technology with expert support to assist cancer centers in achieving their goals and addressing challenges in clinical quality, operational efficiency, and technology utilization. The acquisition aims to empower clinicians and patients worldwide, improving cancer care delivery.
Varian, a Siemens Healthineers company, announced today that it has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services. The acquisition of Aspekt Solutions will expand Varian’s Advanced Oncology Solutions (AOS) offerings and increase the ability to address the rising demand for customized services and standardized care delivery.
Cancer care is evolving rapidly, and providers face numerous challenges, including the rising cost of care, technological complexity, and a shortage of skilled personnel. While navigating these challenges, cancer centers strive to meet several competing objectives in clinical quality, operational efficiency, and technology utilization. Through AOS, Varian offers tailored engagements that harness the power of technology and combine it with professional support from world-class experts with diverse clinical and operational experience. These teams collaborate with cancer centers to help them realize their unique goals for expanding, upgrading, or standardizing operations while implementing global best practices in cancer care.
“Through our AOS offerings, we’ve been leading the way in melding innovative technology with clinical expertise to help address these challenges,” commented Chuck Lindley, Vice President of AOS, at Varian. “With Aspekt Solutions, we can support more oncology centers with a holistic approach to addressing today’s challenges while also preparing for the fast-evolving future of cancer care.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“As part of Varian, we are confident that we will have more opportunities to empower clinicians and patients around the world,” added Brian Pellegrini, CEO of Aspekt Solutions. “We are excited to continue our mission of bringing together the best team of physicists, dosimetrists, and consultants in the industry and partnering with clients to support and extend their existing programs and prepare them for the future. Our immediate focus will be on ensuring that the transition is as smooth as it is beneficial for customers and Aspekt Solutions employees.”
Source: BioSpace